IMARC Group, a leading market research company, has recently releases report titled “Transdermal Skin Patches Market Report by Type (Single-layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Matrix, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Stores), Application (Pain Relief, Smoking Reduction and Cessation Aid, Overactive Bladder, Hormonal Therapy, and Others), and Region 2024-2032”, Offers a comprehensive analysis of the industry, which comprises insights on the global transdermal skin patches market share.
How Big is the Transdermal Skin Patches Market?
The global transdermal skin patches market size reached US$ 7.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.2 Billion by 2032, exhibiting a growth rate (CAGR) of 3.9% during 2024-2032.
Factors Affecting the Growth of the Transdermal Skin Patches Industry:
- Convenience and Patient Compliance:
Transdermal skin patches offer a convenient and non-invasive method of drug delivery, enhancing patient compliance and adherence to medication regimens. By simply applying the patch to the skin, patients can receive a controlled and sustained release of medication over an extended period, eliminating the need for frequent dosing or injections. This convenience is particularly beneficial for patients with chronic conditions who require long-term therapy, as well as for those who have difficulty swallowing pills or adhering to complex medication schedules.
- Technological Advancements:
Continuous advancements in drug delivery technology have led to the development of more efficient and versatile transdermal patch systems. These innovations include the use of microneedles, iontophoresis, and novel formulations that enhance drug permeability through the skin barrier, allowing for improved absorption and bioavailability of medications. As a result, transdermal patches are now capable of delivering a wider range of drugs, including small molecules, peptides, and biologics, with enhanced efficacy and precision.
- Rising Prevalence of Chronic Diseases:
The increasing prevalence of chronic diseases, such as cardiovascular disorders, diabetes, and chronic pain conditions, is driving the demand for transdermal skin patches as a preferred method of drug administration. With the aging population and changing lifestyle factors contributing to the global burden of chronic illness, there is a growing need for effective and convenient treatment options. Transdermal patches offer a viable solution by providing controlled release of medications directly into the bloodstream, helping to manage symptoms, improve patient outcomes, and enhance quality of life for individuals living with chronic conditions.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/transdermal-skin-patches-market/requestsample
Leading Companies Operating in the Global Transdermal Skin Patches Industry:
- 3M Company
- AdhexPharma
- LTS Lohmann Therapie-Systeme AG
- Luye Pharma Group
- Medherant Limited
- Nitto Denko Corporation
- Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.)
- Prosolus Inc.
- Samyang Holdings Corporation
- Tapemark
- Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd)
- tesa SE (Beiersdorf AG)
- Teva Pharmaceutical Industries Ltd.
Transdermal Skin Patches Market Report Segmentation:
The report has segmented the market into the following categories:
By Type:
- Single-layer Drug-in-Adhesive
- Multi-layer Drug-in-Adhesive
- Matrix
- Others
Matrix represents the leading segment as it offers versatility in drug formulation, allowing for the incorporation of a wide range of active pharmaceutical ingredients (APIs), including small molecules, peptides, hormones, and even certain biologics.
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Stores
Based on the distribution channel, the market has been divided into hospital pharmacies, retail pharmacies, and online stores.
By Application:
- Pain Relief
- Smoking Reduction and Cessation Aid
- Overactive Bladder
- Hormonal Therapy
- Others
Pain relief dominates the market as it is a pervasive health issue affecting millions of people worldwide, encompassing acute, chronic, and neuropathic pain conditions.
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America’s dominance in the transdermal skin patches market is attributed to highly developed healthcare infrastructure with advanced medical facilities, research institutions, and pharmaceutical companies.
Global Transdermal Skin Patches Market Trends:
Transdermal skin patches are increasingly being developed for a broader range of indications beyond traditional pain management, including hormone replacement therapy, smoking cessation, contraception, and neurological disorders.
This expansion of indications is driven by advancements in drug delivery technology, allowing for the effective and controlled release of various medications through the skin. Besides, with growing concerns about patient comfort, convenience, and adherence to medication regimens, there is a rising preference for non-invasive drug delivery methods like transdermal patches.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
Browse Other Reports:
Global Dicyclopentadiene Market Report 2024-2032
Global Folding Bike Market Report 2024-2032
Fruit Powder Market Growth Report 2024-2032
